Today, the working group of the Verkhovna Rada Committee on National Health will discuss the future draft law on the functioning of the pharmaceutical market. As noted in an exclusive commentary to UNN by MP, member of the Committee Victoria Vagner, the key task is to take into account the interests of all market participants, not just individual players.
We must take into account the interests of all parties. It cannot be that the players are only on one side. There cannot be regulation on one side and no regulation on the other. Because the price is a factor, starting with the manufacturer and ending with pharmacy chains. Therefore, this is a very complicated process, it will not be very fast, so it is important to hear all sides. And when there is a common point, as in the nomination, then we can develop a strategy, and then a legislative act. This is the only way
According to her, representatives from all pharmaceutical market participants, from manufacturers to pharmacies, were invited to the working group meeting to hear their opinions. This will help to develop balanced solutions regarding pricing regulation mechanisms, marketing agreements and retro bonuses.
She also emphasized that the regulation should not harm small pharmacies, especially in villages and frontline areas.
"It is when we regulate only the pharmacy chain that I see the risk of small or social pharmacies disappearing. I just want to remind you that some pharmacy chains are implementing such projects at their own expense. For example, a social pharmacy, a mobile pharmacy in the frontline area, where there are practically none at all. That's why I really appreciate this activity and I don't want people in these areas to be left without medicines. This is very important. Therefore, in order to prevent this from happening, it is we who must sit down and talk to all the participants," emphasized Wagner.
Recall
On Friday, January 24, at a meeting of the Committee on National Health, Ukrainian Health Minister Viktor Lyashko presented a concept for reforming the regulation of the pharmaceutical market. The Ministry of Health's proposals included reducing the price of medicines through electronic trading between manufacturers, limiting the size of discounts, and banning retro bonuses. Not all of the proposed changes were to the liking of MPs, so it was decided to develop a separate draft law that would cover all aspects of the pharmaceutical market. It should take into account the rights and obligations of manufacturers, distributors and pharmacy chains.